Procter & Gamble Health (NSE:PGHL) Asset Impairment Charge : ₹0 Mil (TTM As of Dec. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Procter & Gamble Health Asset Impairment Charge?

Procter & Gamble Health's Asset Impairment Charge for the three months ended in Dec. 2024 was ₹0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

Procter & Gamble Health Asset Impairment Charge Historical Data

The historical data trend for Procter & Gamble Health's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procter & Gamble Health Asset Impairment Charge Chart

Procter & Gamble Health Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Jun21

Jun22

Jun23

Jun24

Asset Impairment Charge

Get a 7-Day Free Trial

Procter & Gamble Health Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Procter & Gamble Health Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Procter & Gamble Health Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Procter & Gamble Health's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Procter & Gamble Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procter & Gamble Health Ltd (NSE:PGHL) » Definitions » Asset Impairment Charge

Traded in Other Exchanges

500126:India

Address

Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099

Website

https://www.pghealthindia.com

Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.

Procter & Gamble Health Headlines

No Headlines